Teratoma of the Lung in a Hemophilic Patient

Berghout, A; Mallens, W. M. C.; Velde, J. te; Haak, H. L.

doi:10.1159/000206768

Cited by 11 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Unless found as part of a larger report, the literature review of solid tumours excluded specific references to any type of lymphoma or Kaposi sarcoma (KS), benign solid tumours or hepatocellular carcinoma (HCC). After these neoplasms were excluded, 159 cases of malignant solid tumours in persons with haemophilia were identified with an age range of 1.9–78 years [8,15,16,18,23,27–77]. A summary of the data can be found in Table 2 .…”

Section: Resultsmentioning

confidence: 99%

Malignancy in patients with haemophilia: a review of the literature

Dunn

2010

Haemophilia

View full text Add to dashboard Cite

Haemophilia A and B are rare X-linked conditions. Elevated rates of HIV and hepatitis C related malignancies in these patients are well reported, however rates of other types of cancers are not. Therefore, a retrospective literature review of cancer in patients with haemophilia was conducted. A Medline search of articles from January 1966 to July 2009 utilizing the keywords haemophilia, leukaemia, malignancy, mortality, neoplasm and cancer was performed. The articles were reviewed and additional relevant publications were located from the references. Data on age, type and severity of haemophilia, HIV status, type of malignancy and outcomes were recorded as available. Thirty-two cases of leukaemia were identified as well as 159 malignant solid tumours. Specific incidence and prevalence rates could not be calculated due to the limited nature of the information available in the reports. Many types of malignancy have been reported in persons with haemophilia irrespective of infection with HIV and hepatitis C yet prevalence and incidence rates compared to the general population remain unknown. Patients with haemophilia can manifest non infectious related malignancies and symptomatic patients should be evaluated accordingly.

show abstract

Section: Resultsmentioning

confidence: 99%